Oregon Administrative Rules
Chapter 332 - OREGON HEALTH AUTHORITY, HEALTH LICENSING OFFICE, BOARD OF DIRECT ENTRY MIDWIFERY
Division 26 - LEGEND DRUGS AND DEVICES
Section 332-026-0010 - Approved Legend Drugs For Maternal Use
Current through Register Vol. 63, No. 9, September 1, 2024
An LDM may administer the following legend drugs as approved by the Board for maternal use:
(1) Anti-Hemorrhagics for use by intramuscular injection includes:
(2) Anti-Hemorrhagics by intravenous infusion is limited to:
(3) Anti-Hemorrhagics for oral administration is limited to:
(4) Anti-Hemorrhagics for rectal administration is limited to Misoprostol (Cytotec).
(5) Resuscitation is limited to medical oxygen and intravenous fluid replacement.
(6) Intravenous fluid replacement includes:
(7) Anaphylactic treatment by subcutaneous injection is limited to Epinephrine.
(8) Local anesthetic includes:
(9) Rhesus Sensitivity Prophylaxis is limited to Rho(d) Immune Globulin (RhoGAM, Gamulin Rh, Bay Rho-D and others).
(10) Tissue adhesive (Dermabond or generic).
(11) Intravenous antibiotics for Group B Streptococcal prophylaxis is limited to the following and is only to be used solely for the purpose of Group B Streptococcal prophylaxis:
Statutory/Other Authority: ORS 676.615 & ORS 687.493
Statutes/Other Implemented: ORS 687.493